GlassScriptPhysician profile
Nabeel Azeem
NPI 1225261480
$12,382.89
in general payments reported to CMS, 2019-2025
10 companies · $756 in 2025
The $756 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2021: $494 · 2022: $7,724 · 2023: $295 · 2024: $2,824 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,320 · Food and Beverage: $1,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,320.00 |
| Food and Beverage | $1,554.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,217.97 | 2019-2025 | Wallflex Duodenal |
| Olympus Medical Systems Corporation | $2,320.00 | 2024 | Single Use Repositionable Clip |
| Olympus America INC. | $606.96 | 2021-2025 | Evis Exera III Colonovideoscope, Visiglide, Single Use Electrosurgical Knife Kd-655 |
| Cook Medical LLC | $423.52 | 2019-2025 | Echotip Insight, Hemospray |
| Steris Corporation | $406.50 | 2024 | |
| Fujifilm Healthcare Americas Corporation | $140.97 | 2023 | Fujifilm |
| Covidien LP | $77.15 | 2019 | |
| Olympus Corporation of The Americas | $74.70 | 2023 | Single Use Aspiration Needle Na-U200h |
| Lumendi LLC | $67.38 | 2025 | |
| Abbvie INC. | $47.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nabeel Azeem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.